Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Talaris Therapeutics Inc (NASDAQ: TALS)

 
TALS Technical Analysis
5
As on 9th Jun 2023 TALS STOCK Price closed @ 2.55 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 6.50 & Strong Sell for SHORT-TERM with Stoploss of 10.73 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

TALSSTOCK Price

Open 2.53 Change Price %
High 2.61 1 Day 0.02 0.79
Low 2.41 1 Week -0.23 -8.27
Close 2.55 1 Month -0.06 -2.30
Volume 262700 1 Year -10.11 -79.86
52 Week High 16.56 | 52 Week Low 0.94
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
TALS
Daily Charts		 TALS
Intraday Charts		 Whats New @
Bazaartrend		 TALS
Free Analysis
 
TALS Important Levels Intraday
RESISTANCE2.94
RESISTANCE2.81
RESISTANCE2.74
RESISTANCE2.66
SUPPORT2.44
SUPPORT2.36
SUPPORT2.29
SUPPORT2.16
 
TALS Forecast May 2024
Share
4th UP Forecast17.72
3rd UP Forecast12.85
2nd UP Forecast9.85
1st UP Forecast6.84
1st DOWN Forecast-1.74
2nd DOWN Forecast-4.75
3rd DOWN Forecast-7.75
4th DOWN Forecast-12.62
 
TALS Weekly Forecast
4th UP Forecast6.02
3rd UP Forecast4.91
2nd UP Forecast4.22
1st UP Forecast3.53
1st DOWN Forecast1.57
2nd DOWN Forecast0.88
3rd DOWN Forecast0.19
4th DOWN Forecast-0.92
 
TALS Forecast2024
4th UP Forecast32.84
3rd UP Forecast23.13
2nd UP Forecast17.12
1st UP Forecast11.12
1st DOWN Forecast-6.02
2nd DOWN Forecast-12.02
3rd DOWN Forecast-18.03
4th DOWN Forecast-27.74
 
 
TALS Other Details
Segment EQ
Market Capital 672285120.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
TALS Address
TALS
 
TALS Latest News
 
Your Comments and Response on Talaris Therapeutics Inc
 
TALS Business Profile
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, and metabolic disorders. Its lead product candidate is FCR001, a novel allogeneic cell therapy that is in Phase II trial for living donor kidney transplant patients. The company is also developing FCR002 in deceased donor kidney transplants; FCR001 in patients with a severe form of scleroderma; and FCR001 for one or more severe non-malignant blood, immune, or metabolic disorders. Talaris Therapeutics, Inc. was founded in 1988 and is headquartered in Louisville, Kentucky. Address: 570 South Preston Street, Louisville, KY, United States, 40202
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service